-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Htg Molecular Diagnostics, Inc quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2014 to Q1 2023.
- Htg Molecular Diagnostics, Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending March 31, 2023 was -$5.05M, a 22.3% increase year-over-year.
- Htg Molecular Diagnostics, Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending March 31, 2023 was -$20.1M, a 7.17% decline year-over-year.
- Htg Molecular Diagnostics, Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$21.6M, a 25.9% decline from 2021.
- Htg Molecular Diagnostics, Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$17.1M, a 17.8% increase from 2020.
- Htg Molecular Diagnostics, Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2020 was -$20.9M, a 8.09% decline from 2019.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)